1. Home
  2. VALN vs KREF Comparison

VALN vs KREF Comparison

Compare VALN & KREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • KREF
  • Stock Information
  • Founded
  • VALN 2012
  • KREF 2014
  • Country
  • VALN France
  • KREF United States
  • Employees
  • VALN N/A
  • KREF N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • KREF Real Estate Investment Trusts
  • Sector
  • VALN Health Care
  • KREF Real Estate
  • Exchange
  • VALN Nasdaq
  • KREF Nasdaq
  • Market Cap
  • VALN 669.2M
  • KREF 595.7M
  • IPO Year
  • VALN 2021
  • KREF 2017
  • Fundamental
  • Price
  • VALN $9.11
  • KREF $9.24
  • Analyst Decision
  • VALN Strong Buy
  • KREF Buy
  • Analyst Count
  • VALN 3
  • KREF 7
  • Target Price
  • VALN $15.33
  • KREF $12.32
  • AVG Volume (30 Days)
  • VALN 65.5K
  • KREF 696.8K
  • Earning Date
  • VALN 08-12-2025
  • KREF 07-22-2025
  • Dividend Yield
  • VALN N/A
  • KREF 10.78%
  • EPS Growth
  • VALN N/A
  • KREF N/A
  • EPS
  • VALN N/A
  • KREF N/A
  • Revenue
  • VALN $201,099,222.00
  • KREF $40,393,000.00
  • Revenue This Year
  • VALN $18.61
  • KREF $27.61
  • Revenue Next Year
  • VALN $25.07
  • KREF N/A
  • P/E Ratio
  • VALN N/A
  • KREF N/A
  • Revenue Growth
  • VALN 21.64
  • KREF N/A
  • 52 Week Low
  • VALN $3.62
  • KREF $8.28
  • 52 Week High
  • VALN $9.10
  • KREF $12.95
  • Technical
  • Relative Strength Index (RSI)
  • VALN 80.93
  • KREF 54.47
  • Support Level
  • VALN $7.15
  • KREF $9.08
  • Resistance Level
  • VALN $7.82
  • KREF $9.29
  • Average True Range (ATR)
  • VALN 0.40
  • KREF 0.20
  • MACD
  • VALN 0.14
  • KREF 0.02
  • Stochastic Oscillator
  • VALN 99.37
  • KREF 85.96

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About KREF KKR Real Estate Finance Trust Inc.

KKR Real Estate Finance Trust Inc is a real estate finance company that focuses on originating and acquiring senior mortgage loans secured by CRE assets. The investment is to originate or acquire senior mortgage loans collateralized by institutional-quality CRE assets that are owned and operated by experienced and well-capitalized sponsors and located in liquid markets with underlying fundamentals. KKR manages investments across multiple asset classes, including private equity, real estates, energy, infrastructure, credit, and hedge funds. The company's investment objective is capital preservation and generating attractive risk-adjusted returns for its stockholders over the long term, through dividends.

Share on Social Networks: